business news in context, analysis with attitude

Benzinga reports that Mark Cuban's Cost Plus Drug Co., which has been focused on reducing the cost of generic and name brand pharmaceuticals, has forged a relationship with Kroger that will have its Cost Plus Drug TeamCubanCard accepted in some 2,000 Kroger pharmacies around the country.

The card, according to the Cost Plus website, "is a brand new way to get great prices on your prescription drugs closer to home! Our card also pays a fair dispensing fee to independent and grocery pharmacies."

“Love to see it! Thanks Kroger!” Cuban tweeted yesterday.

The Cost Plus business model to this point has been focused on e-commerce, cutting out middlemen in the sourcing process as a way of reducing costs and prices.

KC's View:

However they get there, it makes absolute sense for retailers to strive to reduce pharmacy costs - these charges can be onerous for people in a way that is frustrating because we're talking about folks' health and well-being here.

Cuban seems to have found a way to disrupt the system, and so good for him.  And good for Kroger, which because of its size can create significant ripples in this segment.